[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

HRP960054B1 - A process for preparing certain aza cyclohexapeptides - Google Patents

A process for preparing certain aza cyclohexapeptides

Info

Publication number
HRP960054B1
HRP960054B1 HR960054A HRP960054A HRP960054B1 HR P960054 B1 HRP960054 B1 HR P960054B1 HR 960054 A HR960054 A HR 960054A HR P960054 A HRP960054 A HR P960054A HR P960054 B1 HRP960054 B1 HR P960054B1
Authority
HR
Croatia
Prior art keywords
formula
compound
borane complex
nabh4
metal boride
Prior art date
Application number
HR960054A
Other languages
English (en)
Croatian (hr)
Inventor
M. Belyk Kevin
R. Bender Dean
M. Black Regina
L. Hughes David
Leonard William
Original Assignee
Merck & Co. Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co. Inc. filed Critical Merck & Co. Inc.
Publication of HRP960054A2 publication Critical patent/HRP960054A2/hr
Publication of HRP960054B1 publication Critical patent/HRP960054B1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/06Needles ; Sutures; Needle-suture combinations; Holders or packages for needles or suture materials
    • A61B17/06114Packages or dispensers for needles or sutures
    • A61B17/06133Packages or dispensers for needles or sutures of parallelepipedal shape, e.g. made of rectangular or slightly oval panels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/06Needles ; Sutures; Needle-suture combinations; Holders or packages for needles or suture materials
    • A61B17/06114Packages or dispensers for needles or sutures
    • A61B2017/06142Packages or dispensers for needles or sutures having needle- or suture- retaining members, e.g. holding tabs or needle parks
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/27Cyclic peptide or cyclic protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Dentistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medical Informatics (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HR960054A 1995-02-10 1996-02-05 A process for preparing certain aza cyclohexapeptides HRP960054B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/386,618 US5552521A (en) 1995-02-10 1995-02-10 Process for preparing certain aza cyclohexapeptides

Publications (2)

Publication Number Publication Date
HRP960054A2 HRP960054A2 (en) 1997-10-31
HRP960054B1 true HRP960054B1 (en) 2008-07-31

Family

ID=23526350

Family Applications (1)

Application Number Title Priority Date Filing Date
HR960054A HRP960054B1 (en) 1995-02-10 1996-02-05 A process for preparing certain aza cyclohexapeptides

Country Status (21)

Country Link
US (1) US5552521A (sh)
EP (1) EP0808330B1 (sh)
CN (1) CN1127515C (sh)
AR (2) AR001081A1 (sh)
AT (1) ATE309266T1 (sh)
AU (1) AU692071B2 (sh)
BR (1) BR9607721A (sh)
CA (1) CA2211314C (sh)
CZ (2) CZ286683B6 (sh)
DE (1) DE69635405T2 (sh)
EA (1) EA000564B1 (sh)
ES (1) ES2249778T3 (sh)
FI (1) FI120693B (sh)
HK (1) HK1004676A1 (sh)
HR (1) HRP960054B1 (sh)
HU (1) HU229780B1 (sh)
NZ (1) NZ302967A (sh)
SK (1) SK283115B6 (sh)
TW (1) TW515805B (sh)
WO (1) WO1996024613A1 (sh)
YU (1) YU49459B (sh)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0779895B1 (en) * 1994-08-23 1999-11-17 Merck & Co. Inc. An improved process for preparing side chain derivatives of cyclohexapeptidyl lipopeptides
ATE223226T1 (de) * 1994-09-16 2002-09-15 Merck & Co Inc Azazyklohexapeptid-verbindungen
US5952300A (en) * 1996-04-19 1999-09-14 Merck & Co., Inc. Antifungal compositions
HRP970318B1 (en) * 1996-06-14 2002-06-30 Merck & Co Inc A process for preparing certain aza cyclohexapeptides
USRE38984E1 (en) * 1996-09-12 2006-02-14 Merck & Co., Inc. Antifungal combination therapy
US5936062A (en) * 1997-06-12 1999-08-10 Merck & Co., Inc. Process for preparing certain aza cyclohexapeptides
WO2000024694A1 (en) * 1998-10-28 2000-05-04 Eli Lilly And Company Photochemical process for making 1-deoxy-2-keto derivatives
AR035808A1 (es) * 2001-04-12 2004-07-14 Merck & Co Inc Proceso de deshidratacion capaz de minimizar la epimerizacion de un grupo hidroxilo por ciertas equinocandinas
US7214768B2 (en) * 2002-04-08 2007-05-08 Merck & Co., Inc. Echinocandin process
EP1785432A1 (en) * 2005-11-15 2007-05-16 Sandoz AG Process and intermediates for the synthesis of caspofungin.
JP5373606B2 (ja) 2006-07-26 2013-12-18 サンド・アクチエンゲゼルシヤフト カスポファンギン製剤
US20100137197A1 (en) * 2007-06-26 2010-06-03 Sachin Mittal Lyophilized anti-fungal composition
US20090075870A1 (en) * 2007-09-17 2009-03-19 Protia, Llc Deuterium-enriched caspofungin
WO2009142761A1 (en) * 2008-05-21 2009-11-26 Teva Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag Caspofungin bo free of caspofungin co
US8048853B2 (en) 2008-06-13 2011-11-01 Xellia Pharmaceuticals Aps Process for preparing pharmaceutical compound and intermediates thereof
KR20110011704A (ko) * 2008-06-25 2011-02-08 테바 기오기스제르갸르 자르트쾨렌 뮈쾨되 레스즈베니타르사사그 카스포펀진 불순물 a를 함유하지 않는 카스포펀진
EP2240507A2 (en) * 2008-06-25 2010-10-20 TEVA Gyógyszergyár Zártkörüen Müködö Részvénytársaság Processes for preparing high purity aza cyclohexapeptides
WO2010064219A1 (en) 2008-12-04 2010-06-10 Ranbaxy Laboratories Limited Process for the preparation of a novel intermediate for caspofungin
EP2463293A4 (en) * 2009-08-06 2013-06-05 Shanghai Techwell Biopharm Co AZACYCLOHEXAPEPTIDE BZW. ITS PHARMACEUTICAL ACCEPTABLE SALT, MANUFACTURING PROCESS AND USE
CN101792486A (zh) * 2010-04-12 2010-08-04 浙江海正药业股份有限公司 一种合成醋酸卡泊芬净的方法
CN102219832B (zh) * 2010-04-15 2013-08-21 上海天伟生物制药有限公司 一种氮杂环六肽或其盐的纯化方法
CN103180336B (zh) 2010-09-28 2016-06-15 中化帝斯曼制药有限公司荷兰公司 用于分离环六肽的方法
US8927690B2 (en) * 2010-09-29 2015-01-06 Shanghai Techwell Biopharmaceutical Co., Ltd. Process for purifying cyclolipopeptide compounds or the salts thereof
CN102367269B (zh) * 2010-11-10 2013-11-06 上海天伟生物制药有限公司 一种卡泊芬净类似物及其制备方法和用途
CN102367268B (zh) * 2010-11-10 2013-11-06 上海天伟生物制药有限公司 一种卡泊芬净类似物及其用途
CN102367267B (zh) * 2010-11-10 2013-09-04 上海天伟生物制药有限公司 一种卡泊芬净的制备方法
KR101331984B1 (ko) 2010-12-09 2013-11-25 종근당바이오 주식회사 카스포펀진 제조방법 및 그의 신규 중간체
CN102219833A (zh) * 2011-04-18 2011-10-19 深圳市健元医药科技有限公司 一种更加安全的棘白菌类抗真菌药的制备方法
CN102746384B (zh) * 2011-04-22 2016-01-20 上海天伟生物制药有限公司 一种高纯度的卡泊芬净或其盐及其制备方法和用途
US9321779B2 (en) * 2011-04-28 2016-04-26 Unitris Biopharma Co., Ltd. Intermediate for synthesizing caspofungin and preparation method thereof
CN103483426A (zh) * 2012-06-14 2014-01-01 博瑞生物医药技术(苏州)有限公司 一种氮杂环己肽的制备方法
US9636407B2 (en) 2012-11-20 2017-05-02 Fresenius Kabi Usa, Llc Caspofungin acetate formulations
EP3620462A1 (en) 2018-09-04 2020-03-11 Xellia Pharmaceuticals ApS Process for the preparation of caspofungin

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2704030A1 (de) * 1976-02-12 1977-08-18 Sandoz Ag Neue organische verbindungen, ihre herstellung und verwendung
IE910892A1 (en) * 1990-03-19 1991-09-25 Merck & Co Inc Lipopeptide compounds
US5939384A (en) * 1991-10-01 1999-08-17 Merck & Co., Inc. Cyclohexapeptidyl propanolamine compounds
US5378804A (en) * 1993-03-16 1995-01-03 Merck & Co., Inc. Aza cyclohexapeptide compounds
US6268338B1 (en) * 1993-04-30 2001-07-31 Merck & Co., Inc. Cyclohexapeptidyl amine compounds
EP0779895B1 (en) * 1994-08-23 1999-11-17 Merck & Co. Inc. An improved process for preparing side chain derivatives of cyclohexapeptidyl lipopeptides
ATE223226T1 (de) * 1994-09-16 2002-09-15 Merck & Co Inc Azazyklohexapeptid-verbindungen

Also Published As

Publication number Publication date
ES2249778T3 (es) 2006-04-01
DE69635405D1 (de) 2005-12-15
CZ286683B6 (en) 2000-06-14
FI973281A (fi) 1997-08-08
EP0808330B1 (en) 2005-11-09
EP0808330A1 (en) 1997-11-26
FI120693B (fi) 2010-01-29
SK107997A3 (en) 1998-02-04
TW515805B (en) 2003-01-01
HRP960054A2 (en) 1997-10-31
HUP9901085A2 (hu) 1999-09-28
HUP9901085A3 (en) 2000-11-28
HU229780B1 (en) 2014-07-28
MX9706101A (es) 1997-10-31
BR9607721A (pt) 1998-07-14
CN1127515C (zh) 2003-11-12
DE69635405T2 (de) 2006-07-27
EA000564B1 (ru) 1999-12-29
YU49459B (sh) 2006-03-03
AU692071B2 (en) 1998-05-28
CA2211314C (en) 2007-04-17
ATE309266T1 (de) 2005-11-15
YU8496A (sh) 1999-06-15
NZ302967A (en) 1998-11-25
WO1996024613A1 (en) 1996-08-15
SK283115B6 (sk) 2003-02-04
CZ252597A3 (cs) 1998-01-14
AR001081A1 (es) 1997-09-24
AR005462A1 (es) 1999-06-23
AU4914796A (en) 1996-08-27
CA2211314A1 (en) 1996-08-15
CZ286767B6 (cs) 2000-06-14
FI973281A0 (fi) 1997-08-08
CN1173875A (zh) 1998-02-18
US5552521A (en) 1996-09-03
EA199700170A1 (ru) 1997-12-30
HK1004676A1 (en) 1998-12-04

Similar Documents

Publication Publication Date Title
HRP960054B1 (en) A process for preparing certain aza cyclohexapeptides
MA21601A1 (fr) Procede d'alcoylation de 2-amino-purines et intermediaires utiles a cet effet .
AU528275B2 (en) Imidazole derivatives
EP0921417A3 (en) Epoxy/episulfide resin compositions for optical materials
HUT71499A (en) Bicyclo[2.2.2.]octane derivatives pharmaceutical compositions contg. the said compounds and process to prepare them
ES8503667A1 (es) Un procedimiento para la preparacion de nuevos derivados de 2-oxo-imidazolina.
ES8305764A1 (es) Un procedimiento para la preparacion de derivados carbapenen-2-tio-sustituidos.
NZ332798A (en) A process for preparing aza cyclohexapeptides
TW328084B (en) Process for producing guanidine derivatives, intermediates therefor and their production
PL337016A1 (en) Stabilised carbapenemic intermediate compounds and their application in a synthesis process
WO2002092606A8 (fr) Derives d'imidazolidine fusionnes, leur procede de preparation et d'utilisation
TW353660B (en) Novel diarylmethylidenefuran derivatives, process for their preparation and their uses in therapeutics
IE39278B1 (en) Fluoro substituted phenothiazines method for preparation thereof and composaitions
MX2009006164A (es) Fosfonatos reactivos.
DE3265533D1 (en) 7-alpha-alkoxycarbonyl-15-beta-16-beta-methylene-4 androstene, process for their preparation and their utilization as pharmaceutical preparations
HRP20000027B1 (en) Process for the preparation of alkoxyfuranoneamine derivatives, compounds obtained by this process, and the use of these compounds
DE68924991D1 (de) 2-Pyranon-Derivat und Verfahren zu dessen Herstellung.
IE820486L (en) Piperazinoquinazoline antihypertensives.
Fasseur et al. Electrochemical synthesis of the vinylogs of N-acyl N, O-acetals and their reactivity
Mochizuki et al. Preparation of Optically Pure (S)(+)-2-Oxothiazolidine-4-carboxylic Acid from a Racemate by Microbial Degradation of the (R)-Enantiomer
AU7480191A (en) 3'-o-tosylcytidine and cytosine compounds, and process for production thereof
MY141464A (en) Method for large-scale production of di(uridine 5')-tetraphosphate and salts thereof
YU90192A (sh) LANOSTA-7,9-DIEN-3β, 32-DIOL I POSTUPAK ZA NJEGOVO DOBIJANJE,9-DIEN-3BETA, 32-DIOL I POSTUPAK ZA NJEGOVU SINTEZU
TW353071B (en) Chromene compounds with neutroleptic activity, their preparation and pharmaceutical compositions
TW257749B (en) Process for producing polycyclic compounds

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
B1PR Patent granted
PNAN Change of the applicant name, address/residence

Owner name: MERCK SHARP & DOHME CORP., US

PNAN Change of the applicant name, address/residence

Owner name: MERCK SHARP & DOHME CORP., US

Owner name: SCHERING CORPORATION, US

ODRP Renewal fee for the maintenance of a patent

Payment date: 20150203

Year of fee payment: 20

PB20 Patent expired after termination of 20 years

Effective date: 20160205